Search - tctmd.com

Displaying 21 - 40 of 532

Sort: Relevancy | Date

Presentation THT 2023

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Presenter: NULL

March 22, 2023

Presentation THT 2023

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Presenter: Gregg Stone

March 20, 2023

Presentation ACC 2023

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Presenter: Gregg W. Stone

March 05, 2023

Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

Presentation TCT 2022

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

Presenter: Gregg W. Stone

September 19, 2022

Presentation TCT 2022

It’s About Time We Started Assessing and Treating Vulnerable Plaque

Presenter: Gregg W. Stone

September 18, 2022

Presentation TCT 2022

COSIRA-II – Trial Design and Status Update

Presenter: Gregg Stone

September 18, 2022

Presentation TCT 2022

Reshaping the Failing Heart by Tethering the Bases of the Papillary Muscles

Presenter: Gregg Stone

September 18, 2022

Presentation TCT 2022

We Should Be Offering More PCI to Patients With Complex Multivessel Disease

Presenter: Gregg W. Stone

September 17, 2022

Presentation TCT 2022

The V-Wave Study: Different Device, Different Study Population, and Perhaps Different Results?

Presenter: Gregg W. Stone

September 17, 2022

Presentation CTO 2022

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

Presenter: Gregg Stone

February 25, 2022

Presentation THT 2022

ALIVE IDE Pivotal Trial Update

Presenter: Gregg Stone

February 02, 2022

Presentation THT 2022

PROTECT IV: A Transcatheter Heart Failure Therapy Trial

Presenter: Gregg Stone

February 01, 2022

Presentation THT 2022

Special Challenges of Heart Failure Device Trials

Presenter: Gregg Stone

February 01, 2022

Presentation Controversies and Advances 2021

Optimal Management of Left Main Disease in 2021

Presenter: Gregg W. Stone

December 03, 2021

Presentation TCT 2021

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

LV Reconstruction II: Bioventrix

Presenter: Gregg Stone

November 06, 2021

Advertisement

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

It’s About Time We Started Assessing and Treating Vulnerable Plaque

COSIRA-II – Trial Design and Status Update

Reshaping the Failing Heart by Tethering the Bases of the Papillary Muscles

We Should Be Offering More PCI to Patients With Complex Multivessel Disease

The V-Wave Study: Different Device, Different Study Population, and Perhaps Different Results?

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

ALIVE IDE Pivotal Trial Update

PROTECT IV: A Transcatheter Heart Failure Therapy Trial

Special Challenges of Heart Failure Device Trials

Optimal Management of Left Main Disease in 2021

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

LV Reconstruction II: Bioventrix

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content